Skip to main content

Regulus Therapeutics Inc.

RGLSDelisted Jun 25, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001505512

Regulus Therapeutics Inc. was delisted on Jun 25, 2025; its insiders filed their last Form 4 on Jun 27, 2025; 75 institutions reported holding it in 13F filings for Q1 2025, worth $107.0M in total; no superinvestor held it.

13F holders, Q3 2023

Institutional positions in Regulus Therapeutics Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
25
0 vs. Q2 2023
Shares held
10.9M
+727.3K (+7.1%) vs. Q2 2023
Total value
$15.0M
+$51.7K (+0.3%) vs. Q2 2023
New holders
2
7 more added
Sold out
2
5 more reduced

1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RGLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2023: 25 institutions
Q1 2021: 44 institutionsQ2 2021: 45 institutionsQ3 2021: 42 institutionsQ4 2021: 38 institutionsQ1 2022: 37 institutionsQ2 2022: 28 institutionsQ3 2022: 25 institutionsQ4 2022: 28 institutionsQ1 2023: 27 institutionsQ2 2023: 26 institutionsQ3 2023: 25 institutionsQ4 2023: 26 institutionsQ1 2024: 45 institutionsQ2 2024: 63 institutionsQ3 2024: 70 institutionsQ4 2024: 69 institutionsQ1 2025: 75 institutionsQ2 2025: 1 institutionQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ3 2023: $15.0M
Q1 2021: $42.6MQ2 2021: $18.7MQ3 2021: $15.9MQ4 2021: $9.54MQ1 2022: $18.1MQ2 2022: $12.6MQ3 2022: $13.8MQ4 2022: $11.1MQ1 2023: $6.82MQ2 2023: $15.0MQ3 2023: $15.0MQ4 2023: $14.2MQ1 2024: $147.3MQ2 2024: $109.5MQ3 2024: $89.1MQ4 2024: $84.5MQ1 2025: $107.0MQ2 2025: $760Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding RGLS and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20251$760
Q1 202575$107.0M
Q4 202469$84.5M
Q3 202470$89.1M
Q2 202463$109.5M
Q1 202445$147.3M
Q4 202326$14.2M
Q3 202325$15.0M
Q2 202326$15.0M
Q1 202327$6.82M
Q4 202228$11.1M
Q3 202225$13.8M
Q2 202228$12.6M
Q1 202237$18.1M
Q4 202138$9.54M
Q3 202142$15.9M
Q2 202145$18.7M
Q1 202144$42.6M

Institutions, Q3 2023

Shares, value and share of portfolio for each institution holding Regulus Therapeutics Inc.; share changes are against Q2 2023.

Institutions holding RGLS in Q3 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Federated Hermes, Inc.3,875,578$5.35M0.01%00.0%Unchanged
FMR LLC2,922,600$4.03M0.00%+716,000+32.4%Added
NEA Management Company, LLC1,945,579$2.67M0.21%00.0%Unchanged
DAFNA Capital Management LLC1,111,049$1.52M0.47%00.0%Unchanged
Vanguard Group Inc285,050$390.5K0.00%+2,390+0.8%Added
Victory Capital Management Inc233,207$321.8K0.00%+11,701+5.3%Added
Sarissa Capital Management LP185,183$253.7K0.03%00.0%Unchanged
Geode Capital Management, LLC122,521$169.1K0.00%+9,899+8.8%Added
Renaissance Technologies LLC50,100$69.0K0.00%+4,000+8.7%Added
State Street Corp41,719$57.6K0.00%00.0%Unchanged
Prelude Capital Management, LLC40,260$55.2K0.00%−400−1.0%Reduced
Virtu Financial LLC25,921$36.0K0.00%+25,921New
Northern Trust Corp17,978$24.6K0.00%00.0%Unchanged
Commonwealth Equity Services, LLC17,500$24.0K0.00%00.0%Unchanged
Citadel Advisors LLC11,715$16.2K0.00%−16,090−57.9%Reduced
Grimes & Company, Inc.10,547$14.4K0.00%+184+1.8%Added
Tower Research Capital LLC (TRC)3,586$4.91K0.00%−4,243−54.2%Reduced
Community Bank, N.A.690$9380.00%00.0%Unchanged
BlackRock Inc.618$8470.00%00.0%Unchanged
UBS Group AG408$5580.00%−3,204−88.7%Reduced
Wells Fargo & Company128$1750.00%+1+0.8%Added
Advisor Group Holdings, Inc.50$680.00%00.0%Unchanged
JPMorgan Chase & Co20$280.00%+20New
Acadian Asset Management LLC466$00.00%00.0%Unchanged
Royal Bank of Canada80$00.00%−126−61.2%Reduced
LPL Financial LLC0$00.00%−18,502−100.0%Sold out
Barclays PLC0$00.00%−225−100.0%Sold out
Endurance Wealth Management, Inc.––––Not filed